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A case of thanatophoric dysplasia type I with an 
R248C mutation in the FGFR3 gene
Thanatophoric dysplasia (TD) is a short-limb neonatal dwarfism syn-
drome that is usually lethal in the perinatal period. It is characterized 
by shortening of the limbs, severely small thorax, large head with 
a prominent forehead, macrocephaly, curved femur, and flattened 
vertebral bodies. These malformations result from the mutation in 
fibroblast growth factor receptor 3 (FGFR-3) gene which is located 
on the short arm of chromosome 4. A definite diagnosis should be 
established by molecular genetic analysis to find out the abnormal 
mutations in the FGFR3 gene.  We confirmed by detection of a R248C 
mutation in the FGFR3 gene in DNA analysis. 
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short pelvis. To our knowledge, there have only been about 20 cases 
of clinically diagnosed TD reported in Korea. Most of them were 
diagnosed by prenatal ultrasound and all these pregnancies were 
terminated. There were a few neonatal cases that were diagnosed 
clinically and radiologically, but none of the cases was confirmed by 
DNA analysis. We report a case of thanatophoric dysplasia type I 
which was diagnosed by the detection of the Arg248Cys mutation 
in DNA analysis. 
Case report
A male baby was born by Cesarean delivery due to breech 
presentation and respiratory distress at the gestational age of 36 
weeks and 2 days. 
The baby's mother was a 19-year-old primigravida, single 
Introduction
Thanatophoric dysplasia (TD) is a lethal chondrodysplasia 
caused by fibroblast growth factor receptor 3 (FGFR3) gene 
mutation which is located on the short arm of chromosome 4. 
The most frequent mutations (p.R248C, p.S249C, p.Y373C) 
create a cysteine residue within the extracellular domain. It was 
first described in 1967 by Maroteaux and Lamy
1). It is the most 
common form of lethal congenital skeletal dysplasia, with an 
incidence of 1 in 20,000 to 40,000 live births
2). TD is divided into 
type I, characterized by micromelia with bowed femurs and type II, 
characterized by micromelia with straight femurs. Other features 
of type I and type II include: short limbs, large head with frontal 
bossing, depressed nasal bridge, narrow thoracic cage with severe 
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mother and did not undergo any antenatal evaluation. She visited 
our hospital when her labor pains started. The prenatal two-
dimensional ultrasound examination just before the delivery 
showed polyhydramnios and short-limbed dwarfism. She had no 
history of drug, alcohol, or tobacco abuse. The baby's parents were 
healthy, and there was no family history of congenital abnormalities. 
At birth, the baby's heart rate and body temperature were 52 beats/
min and 36.7℃, respectively. His Apgar score was 1 and 1 at 1 
and 5 minutes, respectively. General appearance was cyanotic blue 
colored. The findings of arterial blood gas analysis showed: pH 7.08, 
PaO2 44.7 mmHg, PaCO2 61.1 mmHg, HCO3 13.9 mmol/L and 
oxygen saturation was 75%, in spite of the oxygen therapy by face 
mask. 
He was intubated and resuscitated immediately and then trans-
ferred to the neonatal intensive care unit. The infantogram showed 
a small thoracic cage and consistent with respiratory distress 
syndrome, including both lung fields with inadequate inspiration of 
white out. The surfactant replacement therapy was performed with 
mechanical ventilation in the assist-control mode. After that, the 
baby's respiratory and hemodynamic status had been stabilized. 
The laboratory findings on admission day were WBC 24,760/
mm
3 (neutrophils 47%, lymphocytes 38%), a hemoglobin level of 
17.7 g/dL, hematocrit 54.8%, platelet 239,000/mm
3, serum Na 135 
mmol/L, K 4.5 mmol/L, AST/ALT 59/14 IU/L, BUN/Cr 11.6/0.7 
mg/dL, and CRP was non-reactive. 
The body weight at birth was 2,740 g (25-50th percentile) and 
height was 39 cm (<5th percentile). The head circumference was 
39.5 cm (>90th percentile), the thoracic circumference was 27 cm 
and the abdominal circumference was 30 cm. He had a large head 
with prominent forehead and midfacial hypoplasia, narrow thorax, 
very short limbs with a short neck, and a protuberant abdomen (Fig. 
1). 
The radiographs showed a large calvaria with a small cranial 
base, marked thinning and flattening of the vertebral bodies, short 
ribs, hypoplasia of the pelvic bones, and small curved long bones so 
called telephone receiver femur (Fig. 2). 
The baby was examined for R248C mutation by use of restriction 
digestion and direct sequencing. The results showed that the baby 
carried R248C mutation. In this case, nucleotide sequence analysis 
of cDNA revealed a C to T transition at nucleotide 742 (C742T) 
in one allele of the FGFR3 gene. This heterozygous 742C →   T 
Fig. 1. Full-body photograph acquired on the 2
nd day of life, showing 
large head, markedly short limbs, and narrow thorax.
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Fig. 2. Newborn infantogram demonstrating thanatophoric dysplasia type I (TD1) findings, including 
platyspondyly, a severely hypoplastic pelvis, long bone shortness (A), hypoplasia of the lungs and 
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(R248C) mutation in the FGFR3 leading to an Arg248Cys (CGC 
→    TGC) substitution (Fig. 3). This genetic condition causing type 
I thantophoric dysplasia. Despite of the mechanical ventilation, the 
baby's oxygen saturation levels are decreased day by day. Finally 
the baby died of respiratory failure, due to narrow thorax with 
pulmonary hypoplasia at 4 months of age. 
Discussion
The term thanatophoric dysplasia (TD) originates from a Greek 
term for "death bearing". TD is characterized by an abnormal 
head, face, thorax and skeleton. The head anomaly consists of 
megacephaly, occasionally with a cloverleaf–shaped skull known 
as kleeblattschödel. In the face, excess skin usually yields a "boxers’ 
face" appearance, with frontal bossing and a depressed nasal bridge. 
A hypoplastic thorax is common, which is disproportionately small 
in relation to the abdomen. Classically, a bell-shaped thorax has 
the shape of a champagne bottle cork and results in pulmonary 
hypoplasia. Ribs are hypoplastic, and the long bones of the 
extremities are short and curved, resulting in telephone receiver–
shaped femurs. Vertebrae are flattened with diminution of the 
intervertebral spaces
3-5). 
Based on bone deformity pattern, TD has been divided into 
two types. Type I is more common and is characterized by curved 
long bones (with a ‘telephone receiver’ appearance) and severe 
platyspondylia, usually without a cloverleaf skull. In type II, the 
long bones are relatively straight, the platyspondylia is less severe, 
and a cloverleaf skull is usually present
6). Affected individuals 
generally die within minutes or days after birth, usually from 
respiratory failure. 
TD is an autosomal dominant disorder caused by sporadic de 
novo mutations in the FGFR3 gene mapped chromosome band 
4p16.32). The FGFR3 gene is a cell surface protein consisting 
of extracellular, transmembrane and intracellular domains. It is 
particularly abundant in the cartilage growth plates
7). Mutations in 
different domains of the FGFR3 gene are responsible for a variety 
of chondrodysplasias ranging from very mild hypochondroplasia 
to lethal TD including chondrodysplasia and Crouzon syndrome
8). 
Essentially, all TD patients examined so far have had mutations 
in the transmembrane domains of FGFR3. TD II cases have a 
single recurrent mutation (A to G) in the tyrosine kinase domain 
of FGFR3, but TD I cases have different mutations affecting either 
the extracellular or intracellular domains of FGFR3
8). Although, 
a total of 12 distinct missense mutations have been described for 
TD I cases, the most common TD I mutation is a C to T transition 
(C742T) that leads to substitution of arginine by cysteine in 248 
position of polypeptide (R248C) in the extracellular domain of 
FGFR3
9).
Molecular analysis of the FGFR3 gene using PCR-based methods 
is useful for the rapid screening of fetuses with sonographic find-
ings suggestive of TD
9). Early prenatal diagnosis of TD can be 
established by ultrasonography in the second trimester of gestation. 
However, it is not always possible to differentiate TD from other 
skeletal dysplasias by ultrasonography alone; thus, molecular 
genetic analysis of the fibroblast growth factor receptor 3 (FGFR3) 
gene is useful for the prenatal diagnosis of TD. Prenatal diagnosis 
can allow for elective abortion to be carried out, thereby avoiding 
possible complications such as later caesarean section, difficult 
vaginal delivery due to hydrocephalus, and malpresentation later in 
the pregnancy
10).
The overall prognosis is poor. Most patients die of respiratory 
insufficiency due to reduced chest circumference and hypoplastic 
lung within 48 hours, although four to nine year survivals have 
been reported
11, 12).
The first case of TD in Korea was reported in 1989
13), and there 
have been about 20 cases described since then. Most of the cases 
have been reported by obstetricians because they were diagnosed by 
the prenatal ultrasound and subsequently terminated. 
However, this was the case of a single mother who had never 
had any prenatal evaluation until just before the delivery. The baby 
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had typical TD I findings, such as a large head with a prominent 
forehead, a flat face, micromelia with telephone receiver femurs, 
and a narrow chest. Moreover, the Arg248Cys mutation in the 
extracellular region of the FGFR3 gene was identified with 
molecular study. 
This case is the first report of a TD type I confirmed both ra-
diolo  gically and genetically in Korea. 
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